Most significant findings (FDR < 0.01)
(grouped by sex and model)
CpG info		EWAS results		Regulatory regions1			Genes1
CpG ID	Position (chrX)2	Effect size3	FDR	Ensembl ID	Region type	Position2	Ensembl ID	Description	Gene ID	Position2
Girls - Model 1
cg25034591	24,073,134	−0.52	3.77 × 10−3	ENSR00000245352	Promoter	chrX:24,071,400-24,075,401	ENSG00000130741	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa [Source:HGNC Symbol;Acc:3267]	EIF2S3	chrX:24,072,833-24,096,088
cg13866977	112,051,826	0.32	3.77 × 10−3	ENSR00001768065	Enhancer	chrX:112,050,201-112,053,200	ENSG00000126016	angiomotin [Source:HGNC Symbol;Acc:17810]	AMOT	chrX:112,017,731-112,084,043
cg26175661	114,826,443	0.28	5.71 × 10−3	NA	NA	NA	ENSG00000102024	plastin 3 [Source:HGNC Symbol;Acc:9091]	PLS3	chrX:114,795,501-114,885,181
Girls - Model 2
cg25034591	24,073,134	−0.54	1.48 × 10−3	ENSR00000245352	Promoter	chrX:24,071,400-24,075,401	ENSG00000130741	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa [Source:HGNC Symbol;Acc:3267]	EIF2S3	chrX:24,072,833-24,096,088
cg13866977	112,051,826	0.33	1.48 × 10−3	ENSR00001768065	Enhancer	chrX:112,050,201-112,053,200	ENSG00000126016	angiomotin [Source:HGNC Symbol;Acc:17810]	AMOT	chrX:112,017,731-112,084,043
Girls - Model 3
cg25034591	24,073,134	−0.52	4.46 × 10−3	ENSR00000245352	Promoter	chrX:24,071,400-24,075,401	ENSG00000130741	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa [Source:HGNC Symbol;Acc:3267]	EIF2S3	chrX:24,072,833-24,096,088
cg13866977	112,051,826	0.32	4.46 × 10−3	ENSR00001768065	Enhancer	chrX:112,050,201-112,053,200	ENSG00000126016	angiomotin [Source:HGNC Symbol;Acc:17810]	AMOT	chrX:112,017,731-112,084,043
cg26175661	114,826,443	0.28	7.50 × 10−3	NA	NA	NA	ENSG00000102024	plastin 3 [Source:HGNC Symbol;Acc:9091]	PLS3	chrX:114,795,501-114,885,181
Girls - Model 4
cg25034591	24,073,134	−0.54	1.72 × 10−3	ENSR00000245352	Promoter	chrX:24,071,400-24,075,401	ENSG00000130741	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa [Source:HGNC Symbol;Acc:3267]	EIF2S3	chrX:24,072,833-24,096,088
cg13866977	112,051,826	0.32	1.72 × 10−3	ENSR00001768065	Enhancer	chrX:112,050,201-112,053,200	ENSG00000126016	angiomotin [Source:HGNC Symbol;Acc:17810]	AMOT	chrX:112,017,731-112,084,043
Boys - Model 1
cg00920314	84,189,177	0.33	3.39 × 10−6	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
cg04516011	84,189,179	0.26	4.96 × 10−6	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
Boys - Model 2
cg00920314	84,189,177	0.32	4.61 × 10−6	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
cg04516011	84,189,179	0.26	4.61 × 10−6	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
Boys - Model 3
cg00920314	84,189,177	0.32	9.33 × 10−6	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
cg04516011	84,189,179	0.25	9.33 × 10−6	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
Boys - Model 4
cg00920314	84,189,177	0.31	1.15 × 10−5	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
cg04516011	84,189,179	0.25	1.15 × 10−5	NA	NA	NA	ENSG00000229547	ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene) [Source:HGNC Symbol;Acc:28656]	UBE2DNL	chrX:84,189,157-84,189,896
1 NA = Not applicable
2 genome build GRCh 37
3 Color shading reflects the magnitude and the sign of the estimated effect - from dark red (strong negative effect), through beige (weak negative effect), and dark blue (strong positive effect).